Turning Point Therapeutics Company
Turning Point Therapeutics is a structure-based drug design pharmaceutical company.
%20.jpg)
Technology:
Anti-infective Drugs
Estimated Revenue:
$50M to $100M
Founded Date:
2013
Total Funding:
$720.7M
Investor Type:
For Profit
Headquarters:
San Diego, California, United States
Funding Status:
IPO
Last Funding Type:
Post-IPO Equity
Employee Number:
51-100
Industry:
PharmTech
Investors Number:
11